It is China's first and only domestic "three-in-one" single-tablet combination Class 1 new drug for HIV treatment. As a new-generation non-nucleoside combination preparation, it has been included ...
Committed to innovation, taking Ainuovirine as the core product, Aidea is going deep in the development of a series of novel anti-HIV products with independent intellectual property rights, and actively promoting the R&D in HIV/ AIDS treatment.
Human urine contains a variety of trace active ingredients that have therapeutic effects on diseases. Aidea Pharma uses urine as a source to extract and purify ...
